{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:52:27Z","timestamp":1787885547185,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016175","name":"Chulabhorn Royal Academy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.phymed.2023.155018","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T01:58:43Z","timestamp":1691805523000},"page":"155018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7256-9982","authenticated-orcid":false,"given":"Taweegrit","family":"Siripongboonsitti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0140-9866","authenticated-orcid":false,"given":"Teerapat","family":"Ungtrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriangkrai","family":"Tawinprai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirayu","family":"Auewarakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wipada","family":"Chartisathian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thitikan","family":"Jansala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rattana","family":"Julsawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8053-2984","authenticated-orcid":false,"given":"Kamonwan","family":"Soonklang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6383-6580","authenticated-orcid":false,"given":"Nithi","family":"Mahanonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chulabhorn","family":"Mahidol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.phymed.2023.155018_bib0001","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S1473-3099(21)00685-X","article-title":"Increased risk of hospitalisation and death with the delta variant in the USA","volume":"21","author":"Bast","year":"2021","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.phymed.2023.155018_bib0002","first-page":"229","article-title":"Short Communication on Use of Andrographis Herb (FA THALAI CHON) for the Treatment of COVID-19 Patients","volume":"19","author":"Benjaponpitak","year":"2021","journal-title":"J. Thai Tradit. Alternat. Med."},{"issue":"2","key":"10.1016\/j.phymed.2023.155018_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0944-7113(97)80051-7","article-title":"Prevention of common colds with Andrographis paniculata dried extract. A pilot double blind trial","volume":"4","author":"Caceres","year":"1997","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.phymed.2023.155018_bib0004","first-page":"1192","article-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study","volume":"6","author":"Cai","year":"2020","journal-title":"Engineering (Beijing)"},{"key":"10.1016\/j.phymed.2023.155018_bib0005","article-title":"Favipiravir versus arbidol for COVID-19: a randomized clinical trial","author":"Chen","year":"2020","journal-title":"MedRxiv"},{"issue":"1","key":"10.1016\/j.phymed.2023.155018_bib0006","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.1093\/cid\/ciab962","article-title":"Efficacy of early treatment with favipiravir on disease progression among high-risk patients with coronavirus disease 2019 (COVID-19): a randomized, open-label clinical trial","volume":"75","author":"Chuah","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"04","key":"10.1016\/j.phymed.2023.155018_bib0007","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-2004-818938","article-title":"Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy","volume":"70","author":"Coon","year":"2004","journal-title":"Planta Med."},{"issue":"3","key":"10.1016\/j.phymed.2023.155018_bib0008","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00705-021-04956-9","article-title":"Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study","volume":"166","author":"Dabbous","year":"2021","journal-title":"Arch. Virol."},{"key":"10.1016\/j.phymed.2023.155018_bib0009","first-page":"195","article-title":"Comparison of pharmacological effect of four andrographolides","volume":"17","author":"Deng","year":"1982","journal-title":"Chinese Pharmaceut. Bull."},{"key":"10.1016\/j.phymed.2023.155018_bib0010","unstructured":"Department of Medical Service. (2021). Clinical practice guideline to diagnosis, treatment and prevention COVID-19 for physicain and health care provider, 21 July 2021. Retrieved 16 December 2022 from https:\/\/covid19.dms.go.th\/Content\/Select_Landding_page?contentId=139."},{"key":"10.1016\/j.phymed.2023.155018_bib0011","doi-asserted-by":"crossref","unstructured":"Dey, Y.N., Khanal, P., Patil, B., Wanjari, M.M., Srivast, B., Gurav, S.S., & Gaidhani, S.N. (2020). The role of andrographolide and its derivative in COVID-19 associated proteins and immune system.","DOI":"10.21203\/rs.3.rs-35800\/v1"},{"key":"10.1016\/j.phymed.2023.155018_bib0012","unstructured":"Doi, Y.K., M. Ando, M. Kuwatsuka, Y. Ishihara, T Favipiravir Observational Study Group, Fujita Health University. (2021). Favipiravir observational study interim report 3 https:\/\/www.kansensho.or.jp\/uploads\/files\/topics\/2019ncov\/covid19_favip_210419_eng.pdf."},{"issue":"2","key":"10.1016\/j.phymed.2023.155018_bib0013","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/cpt.1844","article-title":"Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection","volume":"108","author":"Du","year":"2020","journal-title":"Clin. Pharmacol. Therapeut."},{"issue":"23","key":"10.1016\/j.phymed.2023.155018_bib0014","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.phymed.2023.155018_bib0015","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1007\/s00330-020-07033-y","article-title":"Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis","volume":"30","author":"Francone","year":"2020","journal-title":"Eur. Radiol."},{"issue":"7","key":"10.1016\/j.phymed.2023.155018_bib0016","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jpn. Acad., Ser. B"},{"issue":"7","key":"10.1016\/j.phymed.2023.155018_bib0017","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1078\/094471102321616391","article-title":"A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis","volume":"9","author":"Gabrielian","year":"2002","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2023.155018_bib0018","article-title":"Favipiravir in patients with early mild-to-moderate COVID-19: a randomized controlled trial","author":"Golan","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"15","key":"10.1016\/j.phymed.2023.155018_bib0019","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phymed.2023.155018_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-90551-6","article-title":"The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials","volume":"11","author":"Hassanipour","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2023.155018_bib0021","unstructured":"Hsu, L.-W., Chang, S.-C., Shen, C.-H., & Chuang, K.-S. (2006). Andrographolide and its derivatives as TNF-alpha antagonists. In: Google Patents."},{"key":"10.1016\/j.phymed.2023.155018_bib0022","article-title":"AVIFAVIR for treatment of patients with moderate coronavirus disease 2019 (COVID-19): interim results of a phase II\/III multicenter randomized clinical trial","author":"Ivashchenko","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.phymed.2023.155018_bib0023","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2023.155018_bib0024","article-title":"Role of favipiravir in the treatment of COVID-19","author":"Joshi","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.phymed.2023.155018_bib49","first-page":"33","article-title":"Real-world experience with favipiravir for the treatment of mild-to-moderate COVID-19 in India","volume":"13","author":"Joshi","year":"2022","journal-title":"Pragmat Obs Res"},{"issue":"2","key":"10.1016\/j.phymed.2023.155018_bib0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.explore.2005.08.008","article-title":"Andrographis paniculata for the treatment of upper respiratory infection: a systematic review by the natural standard research collaboration","volume":"1","author":"Kligler","year":"2006","journal-title":"Explore: J. Sci. Heal."},{"issue":"5","key":"10.1016\/j.phymed.2023.155018_bib0026","article-title":"Andrographis paniculata (Burm. F.) Wall. Ex Nees, andrographolide, and andrographolide analogues as SARS-CoV-2 antivirals? A rapid review","volume":"16","author":"Lim","year":"2021","journal-title":"Nat. Prod. Commun."},{"issue":"3","key":"10.1016\/j.phymed.2023.155018_bib50","first-page":"121","article-title":"Analgesic, antipyretic and antiulcerogenic effects of andrographolide","volume":"57","author":"Madav","year":"1995","journal-title":"Indian J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.phymed.2023.155018_bib0027","first-page":"452","article-title":"Anti-inflammatory activity of andrographolide","volume":"67","author":"Madav","year":"1996","journal-title":"Fitoterapia (Milano)"},{"key":"10.1016\/j.phymed.2023.155018_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101703","article-title":"Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial","volume":"54","author":"McMahon","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.phymed.2023.155018_bib0029","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jmii.2020.03.022","article-title":"Genotype and phenotype of COVID-19: their roles in pathogenesis","volume":"54","author":"Mousavizadeh","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"3","key":"10.1016\/j.phymed.2023.155018_bib0030","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/j.jinf.2020.05.049","article-title":"Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19","volume":"81","author":"Nguyen","year":"2020","journal-title":"J. Infect."},{"issue":"1","key":"10.1016\/j.phymed.2023.155018_bib0031","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2710.2003.00534.x","article-title":"Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials","volume":"29","author":"Poolsup","year":"2004","journal-title":"J Clin. Pharm. Ther."},{"issue":"2","key":"10.1016\/j.phymed.2023.155018_bib0032","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1248\/bpb.29.220","article-title":"Andrographolide inhibits the production of TNF-\u03b1 and interleukin-12 in lipopolysaccharide-stimulated macrophages: role of mitogen-activated protein kinases","volume":"29","author":"Qin","year":"2006","journal-title":"Biol. Pharmaceut. Bull."},{"key":"10.1016\/j.phymed.2023.155018_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.648250","article-title":"A computational approach identified andrographolide as a potential drug for suppressing COVID-19-induced cytokine storm","volume":"12","author":"Rehan","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.phymed.2023.155018_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051267","article-title":"A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping","volume":"9","author":"Romano","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.phymed.2023.155018_bib0035","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1021\/acs.jnatprod.0c01324","article-title":"Anti-SARS-CoV-2 activity of andrographis paniculata extract and its major component andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives","volume":"84","author":"Sa-Ngiamsuntorn","year":"2021","journal-title":"J. Nat. Prod."},{"issue":"2","key":"10.1016\/j.phymed.2023.155018_bib0036","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.bjp.0704493","article-title":"Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism (s) involved in its anti-inflammatory effect","volume":"135","author":"Shen","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2023.155018_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-020-01412-z","article-title":"Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis","volume":"17","author":"Shrestha","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.phymed.2023.155018_bib0038","article-title":"The inhibitory effects of extracts of some herbal medicines on the production of proinflammatory cytokines by in vitro stimulated human blood cells","author":"Thamaree","year":"2000","journal-title":"Thai J. Pharmacol."},{"key":"10.1016\/j.phymed.2023.155018_bib0039","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijid.2020.11.142","article-title":"Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: a randomized, comparative, open-label, multicenter, phase 3 clinical trial","volume":"103","author":"Udwadia","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.phymed.2023.155018_bib0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'Kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.phymed.2023.155018_bib0041","first-page":"359","article-title":"Herbal medicine for cough: a systematic review and meta-analysis","volume":"22","author":"Wagner","year":"2015","journal-title":"Compl. Med. Res."},{"key":"10.1016\/j.phymed.2023.155018_bib0042","article-title":"Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: a randomized controlled trial","author":"Wanaratna","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.phymed.2023.155018_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102916","article-title":"Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: a systematic review and meta-analysis","volume":"58","author":"Weiss","year":"2020","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.phymed.2023.155018_bib0044","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"A minimal common outcome measure set for COVID-19 clinical research","volume":"20","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"13","key":"10.1016\/j.phymed.2023.155018_bib0045","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"129","key":"10.1016\/j.phymed.2023.155018_bib0046","first-page":"35","article-title":"Thailand approves asian herb Andrographis to treat COVID-19","author":"Yearsley","year":"2021","journal-title":"HerbalGram"},{"issue":"8","key":"10.1016\/j.phymed.2023.155018_bib0047","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1002\/ptr.7141","article-title":"Efficacy and safety of Xiyanping injection in the treatment of COVID-19: a multicenter, prospective, open-label and randomized controlled trial","volume":"35","author":"Zhang","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phymed.2023.155018_bib0048","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711323003793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711323003793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:53:48Z","timestamp":1760554428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711323003793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":50,"alternative-id":["S0944711323003793"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2023.155018","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2023.155018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155018"}}